Press Release

View printer-friendly version << Back

vTv Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference

HIGH POINT, N.C.--(BUSINESS WIRE)--Nov. 19, 2018-- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that company management will present a corporate overview at the Piper Jaffray 30th Annual Healthcare Conference on Tuesday, Nov. 27, 2018 at 2:10 p.m. ET in New York City.

A live webcast of the presentation can be accessed here and will be archived for 30 days following the presentation at

vTv Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflammatory disorders.

Source: vTv Therapeutics Inc.

vTv Therapeutics Inc.
Josh Vlasto